LH250117P310000
- 0.00
- 0.000.00%
Labcorp Holdings Newsroom
What Does Labcorp Holdings Inc.'s (NYSE:LH) Share Price Indicate?
Labcorp's New Alliance With Graves Gilbert Clinic Set to Boost Stock
Express News | Labcorp and Graves Gilbert Clinic Announce Strategic Agreement for Lab Operations
Labcorp Launches H5 Bird Flu Test Amid US Outbreak: Stock to Gain?
Health-care Sector Faces Mixed Prospects in 2025, Morgan Stanley Says
Laboratory Corp. Is Maintained at Overweight by Morgan Stanley
Morgan Stanley Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $270
Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order Through Physicians
LH Stock May Gain From Select MAWD Pathology Asset Purchase Deal
Express News | Labcorp: To Acquire Select Assets of Mawd Pathology Group
BofA Securities Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $271
Express News | Labcorp: Finalizes Acquisition of Select Outreach Services From Ballad Health
Possible Bearish Signals With Labcorp Holdings Insiders Disposing Stock
Laboratory Corp. Coverage Assumed by Jefferies at Buy
Labcorp Holdings Analyst Ratings
Jefferies Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $275
The WuXi system welcomes a bullish trend! What is the next catalyst?
Many institutions have indicated that this may be a critical juncture for the healthcare sector.
Trump has promised to significantly reduce corporate taxes! Who are the potential big winners of the tax cuts?
JPMorgan pointed out that companies in the S&P 500 index with an actual tax rate greater than 15% and 80% of revenue coming from the USA are potential beneficiaries of Trump's tax cuts policy, mainly concentrated in the financial and industrial sectors, followed by essential consumer, optional consumer, and medical care sectors.
Labcorp Holdings Insider Sold Shares Worth $877,142, According to a Recent SEC Filing
Express News | Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase Her2-Low Awareness for Metastatic Breast Cancer Patients